Croce M A, Fabian T C, Schurr M J, Boscarino R, Pritchard F E, Minard G, Patton J H, Kudsk K A
Presley Regional Trauma Center, Department of Surgery, University of Tennessee-Memphis 38163, USA.
J Trauma. 1995 Dec;39(6):1134-9; discussion 1139-40. doi: 10.1097/00005373-199512000-00022.
Ventilator-associated pneumonia (PN) is difficult to distinguish from trauma-induced systemic inflammatory response syndrome (SIRS), especially in patients with multiple injuries. Previous work using bronchoscopy and quantitative cultures demonstrated significant bacterial growth in about one-third of patients with clinical evidence of PN. In this prospective study, antibiotic therapy for PN was based solely on quantitative bronchoalveolar lavage (BAL) cultures.
Mechanically ventilated trauma patients underwent bronchoscopy with BAL when they developed clinical evidence of PN: fever (temperature > 100.5 degrees F), white blood cells > 10,000 or > 10% immature forms, purulent sputum, and new or changing infiltrate on chest roentgenogram. Patients with other infections or those receiving antibiotics for any other reason were excluded. Empiric antibiotic therapy for PN was started at the time of BAL. If the quantitative cultures revealed > or = 10(5) colony-forming units (CFU)/mL, that patient was defined as having PN and was treated. If the cultures revealed < 10(5) CFU/mL, that patient was defined as having SIRS, and empiric therapy was stopped.
Forty-three patients (88% blunt, 12% penetrating) underwent bronchoscopy with BAL 55 times. Mean age was 40 and Injury Severity Score was 25. Twenty patients had > or = 10(5) CFU/mL (47%) and 23 had < 10(5) CFU/mL (53%). There were no differences in age, Injury Severity Score, temperature, white blood cell count, or ventilator days before BAL between groups. Sixty-five percent of those with SIRS improved after empiric therapy was stopped (average 3.3 days), and 35% underwent repeat BAL. Three patients with the initial diagnosis of SIRS developed PN (13% of SIRS). Mortality for PN was 15%, compared with 17% for SIRS; no deaths were related to antibiotic therapy.
SIRS, which can mimic PN, is common in trauma patients. These entities can be distinguished by bronchoscopy with BAL. Basing antibiotic therapy solely on quantitative BAL cultures is efficacious in trauma patients.
呼吸机相关性肺炎(PN)很难与创伤性全身炎症反应综合征(SIRS)相区分,尤其是在多发伤患者中。以往使用支气管镜检查和定量培养的研究表明,约三分之一有PN临床证据的患者存在显著的细菌生长。在这项前瞻性研究中,PN的抗生素治疗仅基于支气管肺泡灌洗(BAL)定量培养结果。
机械通气的创伤患者在出现PN临床证据时接受支气管镜检查及BAL:发热(体温>100.5华氏度)、白细胞>10000或未成熟形式>10%、脓性痰,以及胸部X线片上新发或变化的浸润影。排除有其他感染或因任何其他原因接受抗生素治疗的患者。在进行BAL时开始对PN进行经验性抗生素治疗。如果定量培养显示≥10⁵菌落形成单位(CFU)/mL,则该患者被定义为患有PN并接受治疗。如果培养显示<10⁵CFU/mL,则该患者被定义为患有SIRS,经验性治疗停止。
43例患者(88%为钝性伤,12%为穿透伤)接受了55次支气管镜检查及BAL。平均年龄为40岁,损伤严重度评分25分。20例患者的培养结果≥10⁵CFU/mL(47%),23例患者的培养结果<10⁵CFU/mL(53%)。两组患者在年龄、损伤严重度评分、体温、白细胞计数或BAL前的机械通气天数方面无差异。65%的SIRS患者在经验性治疗停止后病情改善(平均3.3天),35%的患者接受了重复BAL。最初诊断为SIRS的3例患者发展为PN(占SIRS患者的13%)。PN患者的死亡率为15%,SIRS患者为17%;无死亡与抗生素治疗相关。
可模拟PN的SIRS在创伤患者中很常见。通过支气管镜检查及BAL可区分这些情况。仅基于BAL定量培养进行抗生素治疗对创伤患者有效。